Skip to content

Development of a VTE risk prediction model for single-type tumor types

Development of a VTE risk prediction model for single-type tumor types

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113471
Enrollment
Unknown
Registered
2025-11-28
Start date
2025-07-24
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VTE

Interventions

Case series:None

Sponsors

The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with a definitive diagnosis of malignant tumor confirmed by histopathology. 2. Patients may be at any stage (treatment, monitoring, or recurrence) at the time of initial study enrollment. 3. Age >=18 years. 4. Visited Henan Cancer Hospital between January 1, 2017, and March 31, 2024.

Exclusion criteria

Exclusion criteria: 1. Patients who were discharged automatically or did not receive any anti-malignant tumor treatment due to non-thrombotic factors. 2. No histopathological diagnostic basis. 3. Incomplete clinical data or follow-up information. 4. Life expectancy of no more than 12 weeks due to concomitant severe underlying diseases such as cardiovascular or cerebrovascular conditions.

Design outcomes

Primary

MeasureTime frame
venous thrombosis;Calibration curves;Decision curve analysis;

Secondary

MeasureTime frame
Receiver operating characteristic curves ;

Countries

China

Contacts

Public ContactHu Zhou

The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

tigerzhoupumc@163.com+86 139 3906 8863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026